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Summary
Background: Complexin binds the SNARE complex at
synapses and regulates exocytosis, but genetic studies indi-
cate contradictory roles: in flies it predominantly inhibits
synaptic vesicle fusion, whereas in mice it promotes evoked
responses.
Results: Here we characterize the complexin mutant in the
nematode Caenorhabditis elegans and reveal bipolar func-
tions in neurotransmission: complexin inhibits spontaneous
fusion of synaptic vesicles but is also essential for evoked
responses. Complexin mutants exhibit a doubling of vesicle
fusion in the absence of extracellular calcium. Even more
profoundly, mutants exhibit an almost complete loss of
evoked responses, and current amplitudes are reduced by
94%. One possible interpretation is that complexin is required
for the stabilization of docked vesicles and that, in its absence,
vesicles may fuse or undock from the plasma membrane.
Consistent with this hypothesis, docked synaptic vesicles
are reduced by 70% in complexin-1 mutants.
Conclusion: These data suggest that the main function of
complexin is to maintain the docked state both by inhibiting
fusion and by promoting priming.
Introduction
During constitutive secretion, vesicles fuse to the cell
membrane and release their cargo. Membrane fusion is medi-
ated by the intertwining of SNARE proteins anchored in the
plasma and vesicle membranes [1]. The SNARE complex
also mediates exocytosis of synaptic vesicles, with SNARE
protein interactions forming the primed state. However, the
fusion process is interrupted, and primed vesicles are held in
a ready state until there is a stimulus. When the neuron is de-
polarized, calcium flows in through voltage-gated ion channels
and relieves the block. Thus, regulated secretion requires
a brake to block fusion and a calcium sensor to relieve the
block. Synaptotagmin contains C2 domains capable of
binding calcium and phospholipids, and it is widely accepted
that synaptotagmin acts as the calcium sensor in synaptic
vesicle fusion [2, 3]. What protein interrupts fusion and holds
vesicles in the docked state? Although synaptotagmin could
also play an inhibitory role in fusion, recent studies suggest
that another SNARE-interacting protein, complexin, may be
responsible for blocking constitutive exocytosis [4–7]. Com-
plexin forms an a helix that binds in the groove between syn-
taxin and synaptobrevin across the middle two-thirds of the
SNARE complex and stabilizes the complex [8]. However,*Correspondence: jorgensen@biology.utah.edu
2These authors contributed equally to this workboth biochemical and genetic experiments designed to test
complexin function are contradictory, and the role of com-
plexin in calcium-driven fusion remains controversial.
In liposome and whole-cell fusion assays, complexin blocks
fusion [9, 10]. Complexin appears to block fusion by interfering
with SNARE zippering [11, 12]. The block is relieved by the
addition of synaptotagmin and calcium [9, 10, 13, 14]. A couple
of biochemical assays suggest that complexin might facilitate
fusion [15, 16]. In these assays, complexin was capable of
increasing the rate of SNARE-mediated liposome fusion,
possibly by stabilizing the SNARE complex [8]. Despite these
studies, the predominant activity observed for complexin in
biochemical studies is to inhibit exocytosis.
By contrast, analysis of mutants indicates that the predom-
inant activity of complexin is to promote exocytosis. In autap-
tic synapses from mutant mice lacking complexin-1 and
complexin-2, evoked release was reduced by 66% [17] and
miniature postsynaptic currents were reduced by 30% [18].
Similarly, loss of complexin in Drosophila results in an approx-
imately 40% reduction in evoked release [19, 20].
Paradoxically, genetic studies in Drosophila also suggest
that complexin blocks exocytosis. In these mutants, synaptic
vesicles fuse to the plasma membrane constitutively. This
increase in rate is due in part to a role in development: fly
mutants exhibit a doubling of the number of active zones.
However, the increase in the rate of spontaneous vesicle
fusion is much larger, nearly 20-fold [19, 20]. Knockdown of
complexin-1 and complexin-2 by RNA interference (RNAi) in
mouse cortical neurons caused a 4-fold increase in sponta-
neous release [12], but the increase in spontaneous release
is not observed in the mouse complexin knockouts [18]. It is
not clear why the knockdown and knockout experiments in
mice exhibit opposite effects on spontaneous vesicle fusion,
but these results underscore the contradictory nature of com-
plexin in synaptic vesicle fusion.
Here we characterize complexin knockouts in the nematode
Caenorhabditis elegans. We demonstrate that complexin-1
plays both facilitatory and inhibitory roles in synaptic vesicle
exocytosis at the neuromuscular junction. Evoked release is
largely absent in cpx-1 mutants, whereas tonic fusions are
increased. These defects are accompanied by a severe
decrease of docked vesicles at the synapse.
Results
The cpx-1 Isoform Functions at the Nematode
Neuromuscular Junction
Two complexin genes, cpx-1 and cpx-2, are predicted in the
C. elegans genome (Figure 1A; see also Figures S1 and S2
available online). Worm cpx-1 exhibits greater identity to the
fly and mouse complexins than cpx-2 (39% identity between
CPX-1 and mouse complexin-1 versus 32% identity between
CPX-2 and mouse complexin-1 (Figure 1; Figure S2).
For CPX-1, highest conservation is observed in the central
helical domain (75%), which binds the SNARE complex,
whereas the N-terminal facilitory domain, the accessory
domain, and the C-terminal domains each exhibit about 30%
identity. The domains of complexin are defined based on
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Figure 1. cpx-1 Encodes the Worm Homolog of
Complexin and Regulates Locomotion and
Neurotransmitter Release
(A) cpx-1 is the complexin gene with the highest
identity to mouse and fly complexins.
C. elegans CPX-1 was aligned with mouse CplxI
(AAH14803) and fly complexin (AAF69518) using
ClustalW2. Percent identities were calculated
using Jalview [33].
(B) cpx-1 is expressed in the nervous system.Top:
gene model and regions deleted in C. elegans
complexin mutant alleles (red bars). The black
line represents the region of the genome used to
create the rescuing GFP construct. Gray triangle
on transcript represents the 30UTR. GFP was
inserted after the first three codons. Bottom:
a reporter construct consisting of the cpx-1 gene
with GFP inserted at the N terminus of complexin
is expressed in many neurons in the head and
body of the animal. Neurons expressing cpx-1
include the motor neurons of the ventral nerve
cord, neurons in the head ganglia, and also
neurons of the pharyngeal nervous system,
including theMCandM4motorneurons. The inset
shows the punctate localization of GFP::CPX-1
along the dorsal nerve cord. Confocal images
were taken of young adult hermaphrodites
oriented dorsal up and anterior to the left. Images
are a stitch of multiple confocal Z projections
along the length of the animal.
(C) cpx-1 mutants are defective for thrashing in
liquid. cpx-1 thrashing behavior can be rescued
by expressing cpx-1 under a panneuronal
promoter (Prab-3::cpx-1 EG4633), but not by ex-
pressing it specifically in the acetylcholine
neurons (Punc-17::cpx-1 EG4713). Graph shows
means and standard error of the mean (SEM) of
the thrashing behavior. Tukey-Kramer multiple
comparisons test: *p < 0.001. The n values for
each strain are listed at the bottom of each bar.
(D) cpx-1mutants are hypersensitive to the acetyl-
cholinesterase inhibitor aldicarb, indicating that
excessive acetylcholine is released at neuromus-
cular junctions. This sensitivity can be rescued
by expressing cpx-1 in all neurons using the rab-
3 promoter. Graph shows means and SEM.
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107sequence conservation across multiple animal phyla (see Fig-
ure S1 legend for full description of how the domains were
defined). To assay for complexin function at neuromuscular
junctions, we analyzed mutations in cpx-1 and cpx-2. cpx-1
(ok1552) deletes the first of two exons of the gene, which
includes the N terminus, the accessory domain, the central
helix, and part of the C-terminal domain. cpx-2(tm1871)
deletes part of the accessory domain, the central helix, and
part of the C-terminal domain of cpx-2 (Figure 1B; Figure S2).
Complexins in mice and Drosophila are required for viability;
complexin-1 complexin-2 double knockout mice die a few
hours after birth, and complexin null flies die before adult eclo-
sion [17, 19]. By contrast, C. elegans cpx-1(ok1552) and cpx-2(tm1871)mutants are viable and grow to
adulthood; similarly, cpx-1(ok1552)
cpx-2(tm1871) double mutants develop
into fertile adults.
Nevertheless, cpx-1(ok1552)mutants
are uncoordinated. To quantify body
movement, we performed thrashingassays. Animals placed in a drop of water will swim by rapid
reciprocal contractions of the body; locomotory activity can
be quantified by counting flexures. Wild-type animals are
capable of maintaining high rates of thrashing, whereas
cpx-1(ok1552) worms exhibit reduced thrashing in liquid (Fig-
ure 1C). cpx-2(tm1871) mutants exhibit no swimming defect,
suggesting that cpx-1, but not cpx-2, is important for the regu-
lation of locomotion (Figure S2). To test whether loss of
complexin results in defective neurotransmission, we tested
the sensitivity of the complexin mutants to the acetylcholines-
terase inhibitor aldicarb. Loss of cpx-1, but not cpx-2, resulted
in hypersensitivity to aldicarb, suggesting that there is exces-
sive neurotransmitter release at the neuromuscular junction
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Figure 2. cpx-1Mutants Exhibit Normal Presynaptic and
Postsynaptic Morphology
Left: sample image of each synaptic reporter. Images for
all strains were taken of the dorsal nerve cord near the
posterior gonad reflex. Right: quantification of the
number of GFP-positive puncta per 10 mm. Ten images
were analyzed for each strain.
(A) cpx-1mutation does not affect the number of synaptic
vesicle clusters visualized by synaptobrevin::GFP
(nIs52).
(B) Normal numbers of synapses are observed in cpx-1
mutants, as visualized by the dense projection marker
a-liprin::GFP (hpIs3).
(C) GFP-tagged GABA receptors (oxIs22) are clustered
normally at postsynaptic sites. Images are confocal
Z stacks of a 70 mm section of the dorsal nerve cord.
n = 10 sections of dorsal nerve cord for each strain. All
graphs show means and SEM for the number of punctae
per 10 mm.
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108(Figure 1D; Figure S2). The thrashing and aldicarb hypersensi-
tivity phenotypes of cpx-1mutants can be fully rescued by ex-
pressing the cpx-1 gene under its own promoter or under
a panneuronal promoter, demonstrating that complexin is
functioning in the nervous system (Figure 1D; Figure S3). The
aldicarb hypersensitivity defect can also be rescued by ex-
pressing cpx-1 in just the acetylcholine neurons, demon-
strating that excess neurotransmitter release arises from
a cell-autonomous defect in the motor neurons (Figure S3A).
However, thrashing was not rescued by expressing cpx-1
specifically in the acetylcholine motor neurons, suggesting
that cpx-1 is required more broadly in the nervous system for
normal locomotion (Figure 1C). cpx-1 cpx-2 double mutants
are not more severe than the cpx-1 single mutant for the
thrashing or aldicarb assays, demonstrating that cpx-1 plays
the dominant role for the locomotory phenotypes (Figure S2).
Together, these data suggest that cpx-1 functions in the motor
neurons to prevent excess neurotransmitter release.
Complexins in other species are expressed mostly in
neuronal tissue [4–6, 19]. To determine the expression pattern
of the C. elegans complexin genes, we tagged the N termini of
CPX-1 and CPX-2 with GFP. Each fusion construct includes
the promoter, all introns, and the native 30 untranslated region
(UTR) (Figure 1B; Figure S2). The cpx-1 transgenic reporter is
widely expressed in the nervous system, including all the
ventral cord motor neurons (Figure 1B). The CPX-1 protein is
clustered into puncta along the dorsal and ventral nerve cords,
suggesting that the protein is likely localized to synapses (Fig-
ure 1B, inset). Because the transgene rescues the cpx-1
aldicarb hypersensitivity phenotype, the tagged protein is
functional (Figure S3). Because no obvious phenotype was
detected for cpx-2, it was not possible to assay rescue.
However the expression pattern suggests that cpx-2 is more
narrowly expressed, including in a few neurons in the head
and tail ganglia and in the coelomocyte scavenger cells, but
not in the motor neurons of the ventral nerve cord (Figure S2).
The expression patterns and behavioral phenotypes suggest
that cpx-1 is the primary complexin functioning at neuromus-
cular junctions.Loss of cpx-1 Has Contradictory Effects on
Synaptic Transmission
Loss of complexin results in a developmental
defect in Drosophila neurons: the numbers ofsynaptic varicosities and active zones are nearly doubled [19].
It is has been suggested that the increase in tonic release leads
to synaptic hypertrophy in Drosophila. To determine whether
there is a developmental defect at C. elegans synapses, we
examined synaptic markers in cpx-1(ok1552) mutants. Normal
numbers of neuromuscular junctions were observed in cpx-1
mutants, as assayedbycounting synaptic vesicle clusters (syn-
aptobrevin-GFP) or dense projections (a-liprin/SYD-2::GFP)
along the ventral nerve cord (Figures 2A and 2B). Normal post-
synaptic receptor fields were observed in cpx-1 mutants by
labeling the muscle GABA receptor (UNC-49::GFP; Figure 2C).
Finally, axon outgrowth appeared to be normal in cpx-1
(ok1552) mutants, as determined by labeling the GABA motor
neurons (Figure S3). It is possible that the synaptic phenotypes
of cpx-1mutants arose from long-term compensatory changes
that occurred during development. To examine a develop-
mental role for cpx-1, we expressed cpx-1(+) under the control
of two different heat-shock promoters in cpx-1(ok1552)mutant
animals (Figure S3). In the absence of heat shock, the trans-
genes failed to rescue the aldicarb hypersensitivity of cpx-1
(ok1552); after heat shock, in adult animals, normal aldicarb
sensitivity was restored. Taken together, these results suggest
that thedevelopment of thenervoussystem ina cpx-1mutant is
grossly normal and that the uncoordinated phenotype and
hypersensitivity to aldicarb are due to defects in synaptic func-
tion rather than an increase in synaptic number.
Hypersensitivity to aldicarb suggests excessive neurotrans-
mitter release at the neuromuscular junction. Three mecha-
nisms of neurotransmitter release could be responsible for
the increase: evoked, tonic, or spontaneous release. Evoked
release is generated by an action potential or a depolarizing
stimulus from an electrode. The transient depolarization
causes an influx of calcium at the synapse and stimulates
the fusion of vesicles in the readily releasable pool. The
coherent release of neurotransmitter produces a large post-
synaptic current. Tonic release occurs even in the absence
of a stimulus. If the membrane potential of the neuron at rest
is sufficiently depolarized, a low level of calcium influx leads
to sporadic vesicle fusion and miniature postsynaptic
TA C
B
D
Figure 3. cpx-1 Mutants Exhibit Elevated Spontaneous
Fusion and Reduced Evoked Responses
(A) Representative traces of wild-type and cpx-1(ok1552)
miniature postsynaptic currents (minis) from unstimu-
lated motor neurons at 0 mM calcium.
(B) Tonic neurotransmitter release at varying calcium
concentrations. Each miniature current represents the
fusion of a single synaptic vesicle. The increased
frequency of miniature currents in cpx-1 mutants at
0 mM extracellular calcium suggests that these vesicles
may be fusing spontaneously in calcium-independent
fusion. Mini frequencies in 5 mM calcium: wild-type
64 6 8 minis/s, cpx-1(ok1552) 61 6 11 minis/s; in 1 mM
calcium: wild-type 55 6 10 minis/s, cpx-1(ok1552)
69 6 9 minis/s; in 0.4 mM calcium: wild-type 44 6 7
minis/s, cpx-1(ok1552) 70 6 10 minis/s (*p < 0.05 versus
wild-type); in 0 mM calcium: wild-type 21 6 2 minis/s,
cpx-1(ok1552) 45 6 6 minis/s (**p < 0.005 versus wild-
type). Probabilities calculated using an unpaired inde-
pendent t test.
(C) Representative traces of electrically evoked res-
ponses at 5 mM calcium of wild-type, cpx-1(ok1552).
(D) Summary of evoked responses from the wild-type
(1903 6 182 nA) and cpx-1(ok1552) (113 6 13 nA). Wild-
type versus cpx-1(ok1552) p < 0.00001 using an unpaired
independent t test. All graphs show means and SEM.
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109currents. Note that tonic release still requires calcium. In the
absence of extracellular calcium, vesicle fusion is very rare
and is called spontaneous fusion.
We measured these three types of neurotransmitter release
using voltage-clamp recordings from neuromuscular junctions
in cpx-1(ok1552) mutants [21]. At 5 mM calcium, tonic release
in cpx-1 mutants was the same as in the wild-type (Figures 3A
and 3B). Tonic release is sensitive to extracellular calcium, so
mini frequencies were measured over a range of calcium
concentrations (Figure 3B). To measure spontaneous release,
we recorded minis in the absence of extracellular calcium.
Note that, even in the absence of extracellular calcium, some
minis areobserved inC. elegans; these residualminis, however,
are dependent on calcium from internal stores [22]. Interest-
ingly, the cpx-1(ok1552)mutants still exhibited a >40% increase
in mini frequency compared to the wild-type at 0 mM calcium.
These results suggest that CPX-1 is required to block sponta-
neous calcium-independent fusion of synaptic vesicles.
To evaluate evoked release, we stimulated the ventral nerve
cordwith an electrode. Evoked releasewas reduced by 94% in
cpx-1(ok1552) animals, demonstrating that the readily releas-
able pool was almost completely absent (Figures 3C and
3D). Once again, the defect in evoked release could be rescued
by expressing cpx-1(+) in the nervous system of the mutant
strain (Figure 5). These data suggest that in addition to an
inhibitory role, complexin is playing a positive role in fusion.
Complexin Plays Dual Roles in Exocytosis
Onepossible interpretationof thesedata is thatcomplexinplays
one role at the synapse: it blocks spontaneous fusion of
synaptic vesicles. In this model, the absence of the evoked
release is caused by a depletion of primed vesicles by sponta-
neous fusion. To assay for a depletion of docked vesicles, we
examinedthenumberanddistributionofsynapticvesiclesusing
electron microscopy. At a gross level, the synapses seem
normal in cpx-1mutants: the morphology is normal (Figure 4A),
synaptic vesicleshaveanormaldiameter (FigureS4C), andvesi-
cles are clustered around the dense projection (Figure S4A).
However, the total number of synaptic vesicles is reduced toabout 50% in cpx-1(ok1552) mutants compared to the wild-
type (Figure 4B). Moreover, the number of docked vesicles is
severely reduced: there is a 70% reduction of docked vesicles
at acetylcholine synapses and a 75% reduction of docked vesi-
cles at GABA synapses (Figure 4C). Docking at the plasma
membrane is reduced along the entire active zone (Figure S4B).
The ultrastructural data are superficially consistent with
complexin having a single function: it blocks spontaneous
fusion. If this model were true, then one would expect that
weak mutations would lead to an increase in spontaneous
fusion and a concomitant decrease in evoked release; that
is, the phenotypes should always be reciprocal. The first 15
amino acids of murine complexin are required for stimulating
neurotransmission [12, 23, 24]. Specifically, the methionine
and lysine residues at positions 5 and 6 in mouse complexin
are believed to mediate the stimulatory effect [23], and these
residues are conserved between mice and worms (Figure 1A).
We deleted sequence coding for the 15 amino acids at the
N terminus of the complexin gene (DN-cpx-1; Figure 5A). To
ensure that constructs were stable and not overexpressed,
we inserted the transgenes as single copies into the cpx-1
(ok1552) genome using Mos-mediated single copy insertion
[25]. A cpx-1(+) gene expressed in neurons rescues the loco-
motory phenotypes and evoked responses and also inhibits
the spontaneous fusion of vesicles (Figures 1C and 1D; Fig-
ure 5). The N-terminal deletion construct partially rescues the
locomotory phenotype (Figure S5). Electrophysiological
recordings demonstrate that spontaneous fusion is increased
in the N-terminal deletion allele compared to the wild-type
(Figures 5B and 5C), suggesting that the N terminus is required
to inhibit spontaneous fusion. Surprisingly, the N-terminal
deletion causes an increase rather than a decrease in evoked
release (Figures 5D and 5E). These data tell us two important
facts about complexin: (1) unlike in the mouse, the N-terminal
domain in the worm inhibits fusion, both evoked and sponta-
neous, and (2) the negative and positive roles of complexin
are separable. The N-terminal domain is required to inhibit
fusion; the stimulatory functions must reside elsewhere. We
conclude that complexin plays dual roles during vesicle fusion.
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Figure 4. cpx-1 Mutants Have Reduced Numbers of
Synaptic Vesicles at the Synapse
(A) Top: representative electron micrographs of a wild-
type and a cpx-1 neuromuscular junction. The following
abbreviations are used: mt, mitochondria; DP, dense
projection; SV, synaptic vesicles. Bottom: high-magnifi-
cation images of a synapse from wild-type (left) and
cpx-1(ok1552) (right) animals. Left: a vesicle docked to
the plasma membrane adjacent to a dense projection at
a wild-type neuromuscular junction. The arrow indicates
the contact between the vesicle and plasma membrane.
Right: a vesicle tethered to the plasma membrane next
to the dense projection in a cpx-1(ok1552) animal. The
arrow indicates the tether connecting the plasma
membrane to the vesicle.
(B) Summary of the total number of synaptic vesicles per
profile containing a dense projection. Wild-type acetyl-
choline neurons: 23.3 6 0.8 vesicles; cpx-1(ok1552)
acetylcholine neurons: 12.5 6 0.8 vesicles (p < 0.0001,
unpaired t test).Wild-typeGABA neurons: 30.96 1.0 vesi-
cles; cpx-1(ok1552) GABA neurons: 15.3 6 1.5 vesicles
(p < 0.0001, unpaired t test).
(C) Total number of docked synaptic vesicles per profile
containing a dense projection. Docked vesicles: wild-
type acetylcholine neurons: 2.3 6 0.1 vesicles; cpx-1
(ok1552) acetylcholine neurons: 0.7 6 0.1 vesicles
(p < 0.0001 unpaired t test). Docked vesicles: wild-type
GABA neurons: 2.8 6 0.2 vesicles; cpx-1(ok1552) GABA
neurons: 0.7 6 0.1 vesicles (p < 0.0001 unpaired t test).
A vesicle is considered docked if it is contacting the
plasma membrane [32]. All graphs showmeans and SEM.
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Contradictory interpretationshavebeen put forward for the role
of complexin in synaptic vesicle fusion: some data suggest that
complexin blocks spontaneous fusion of synaptic vesicles, and
other data suggest that complexin stimulates exocytosis. We
findevidence forbothof these roles in thenematodeC.elegans.
Blocking Fusion
Our data demonstrate that the complexin protein arrests
SNARE-mediated fusion. First, in dissected preparations,
spontaneous vesicle fusion is increased at cpx-1 neuromus-
cular junctions. Second, increased exocytosis occurs in undis-
sected animals as well: complexin mutant animals exhibit an
increased sensitivity to aldicarb, a drug that blocks the degra-
dation of acetylcholine. The increased rate of release is not
simply an increase in tonic release. Tonic release depends
on extracellular calcium, whereas spontaneous release isindependent of extracellular calcium. Thus,
complexin may inhibit the spontaneous fusion
of vesicles from both the evoked and tonic
pools. An inhibitory role for complexin in tonic
fusion is consistent with observations in
both flies and mice. Complexin mutants in
Drosophila exhibit elevated rates of sponta-
neous fusion, as measured by field potentials
at the neuromuscular junction of third instar
larvae [19]. Similarly, knockdown of complexin
in mouse cortical neurons by RNA interference
led to a 4-fold increase in the rate of sponta-
neous fusion [12].
An increased consumption of synaptic vesi-
cles should lead to a depletion of vesicles at
mutant synapses. In C. elegans, spontaneousfusion occurs at high enough levels to deplete both docked
and cytoplasmic pools of vesicles, as observed by electron
microscopy. There is a 70%decrease in the number of vesicles
docked at active zones in cpx-1mutants, presumably because
vesicles spontaneously fuse after the priming of the SNARE
complex. The loss of complexin from theC. elegans neuromus-
cular junction even depletes the reserve pool of vesicles by
50%, indicating that the high rates of fusion are outpacing the
ability of the cell to replenish vesicles at the synapse. Although
an increase in spontaneous fusion is not observed in mouse
knockouts, there is a reduction in the readily releasable pool,
i.e., docked and primed vesicles, as measured by applying
moderately hyperosmotic media [23].
The inhibitory role of complexin in synaptic vesicle fusion is
borne out by biochemical studies of membrane fusion. Com-
plexin can inhibit SNARE-mediated fusion of whole cells [10]
and also block SNARE-mediated fusion of liposomes [9]. The
block of SNARE-mediated fusion appears to involve the
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Figure 5. The N Terminus of cpx-1 Is Not Required for
EvokedReleaseat theC.elegansNeuromuscularJunction
(A) Models of the wild-type and the N-terminal truncation
mutant. The DN-cpx-1 mutant truncates the 15 amino
acids immediately following the start codon (see box in
Figure 1A).
(B) Sample traces of tonic release in 0.4 mM extracellular
calcium.
(C) The DN-cpx-1 does not rescue the spontaneous
release phenotype of cpx-1(ok1552) mutants at 0 mM
extracellular calcium. At 0.4 mM calcium, wild-type 46 6
6 minis/s, cpx-1(ok1552) 706 10minis/s (*p < 0.05 versus
wild-type), cpx-1(ok1552) + rescue (EG4633)
46 6 9 minis/s, DN-cpx-1 (EG6182) 54 6 7 minis/s. At
0 mM extracellular calcium, wild-type 21 6 2 minis/s,
cpx-1(ok1552) 45 6 6 minis/s (**p < 0.005 versus wild-
type), DN-cpx-1 (EG6182) 40 6 5 minis/s (***p < 0.02
versus wild-type). Wild-type complexin is capable of fully
rescuing the null mini frequency.
(D) Sample traces of evoked release from the wild-type,
cpx-1(ok1552), cpx-1(ok1552) + rescue (EG4633), cpx-1
(ok1552) + DN-cpx-1.
(E) Evoked release is rescued in cpx-1(ok1552)mutants by
expressing either wild-type complexin or the N-terminal
truncation mutant DN-cpx-1 in neurons. Wild-type
1903 6 182 nA, cpx-1(ok1552) 113 6 13 nA (*p < 0.001),
cpx-1(ok1552) + rescue (EG4633) 1768 6 186 nA,
DN-cpx-1 (EG6182) 2518 6 215 nA (**p < 0.05) at 5 mM
extracellular calcium. The wild-type and null mutant in
(C) and (E) are recapitulated from Figure 3. n values are
indicated in the bars. All graphs show means and SEM.
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111accessory domain of complexin, which may prevent synapto-
brevin from fully zippering the SNARE complex [9–11].
Stimulating Exocytosis
Complexin is also required for calcium-stimulatedexocytosis in
C. elegans: evoked currents are reduced by 94% in the com-
plexin mutant. These data are also consistent with data from
flies and mice. In Drosophila, complexin mutants exhibit an
approximately 30%–40% decrease in evoked potential [19]. In
mouse cultured neurons, disruption of complexin by mutation
or RNAi knockdown causes an approximately 70% decrease
in evoked responses compared to the wild-type [12, 17, 18].
Thus, loss of evoked synaptic vesicle exocytosis is a common
feature of complexin mutants in all organisms studied.
How can complexin facilitate evoked release when it clearly
inhibits spontaneous fusion of synaptic vesicles? There are
two possible models for the role of complexin in evoked
release. In the first model, complexin has only one function:
to inhibit spontaneous vesicle fusion; the defect in evoked
release is an indirect effect of depletion of the vesicle pool
through spontaneous fusion. In the second model, complexin
also has a domain that facilitates evoked release. In short, in
this second model, complexin has dual functions: to inhibit
spontaneous release of the tonic pool and to facilitate fusion
from the evoked pool.
Stimulating by Inhibiting
In the inhibitory model, rapid consumption of vesicles via
spontaneous fusion depletes vesicles from the evoked pool
(Figure 6, middle). Thus, a role for complexin in stimulating
exocytosis is an illusion of an empty readily releasable pool.
An attractive aspect of this model is its simplicity: complexin
would have a single, uncomplicated function in synaptic
vesicle exocytosis. If this were true, mutations that partiallydisrupt the inhibitory function should also disrupt stimulatory
functions—the phenotypes should always be linked—and
increase in spontaneous fusion should result in a proportional
reduction in the number of vesicles in the readily releasable
pool. By contrast, mutations in the N-terminal domain increase
spontaneous release but do not reduce evoked release
(Figure 5). In fact, evoked release is even higher than in the
wild-type. Similarly, removal of the prenylation motif from
Drosophila complexin, deletion of the C-terminal domain, or
disruption of the central helix of C. elegans CPX-1 exhibits
normal evoked release but increases spontaneous release
(Martin et al. [26], this issue of Current Biology) [27]. Together,
these data suggest that the synapses in worms and flies can
maintain high rates of tonic release without depleting the
evoked vesicle pool.
A Stimulatory Domain
In the dual function model, complexin inhibits spontaneous
release from the tonic pool but facilitates evoked release. We
found in C. elegans that complexin is essential for evoked
release, potentially supporting a dual role for complexin. In
the mouse, the N terminus of complexin is required for evoked
responses possibly to promote a late step in the fusion
process [12, 20, 23]. Surprisingly, when we deleted these resi-
dues in C. elegans complexin, evoked release was not disrup-
ted. These data suggest that residues involved in promoting
fusion are located in a different region of the molecule than
the N terminus in C. elegans.
Stimulating by Docking
How, then,might complexin facilitate evoked release at amolec-
ular level? An alternative model is that complexin facilitates
evoked release via the central helix (Figure 6). The binding of
the central helix domain of complexin to the partially zippered
complexin mutant
wild type
readily-
releasable 
poolcomplexin
synaptobrevin
syntaxin
spontaneous
fusionzipper
undocking
unzipper
Figure 6. Model for Dual Functions of Complexin
Top: complexin functions to maintain primed vesicles in
the readily releasable pool by stabilizing the SNARE
complex in a partially zippered state. Middle: in the
absence of complexin, the SNAREs can fully zipper and
drive membrane fusion, thereby allowing spontaneous
fusion. Bottom: in the absence of complexin, the SNAREs
might unzipper and reverse the docking of vesicles,
thereby depleting evoked responses. Complexin might
provide this stabilizing effect on its own or in conjunction
with other synaptic proteins. The SNARE protein SNAP-
25 is not shown for simplicity.
Current Biology Vol 21 No 2
112SNARE complex could prevent unzippering and the reversal of
theprimedstate [7,8]. Inan invitrovesicledockingassay,binding
by complexin stabilizes the trans configuration [15]. In the
absence of complexin, trans-SNARE complexes are reversible,
and primed vesicleswould become unprimed (Figure 6, bottom).
Such reversal of priming would contribute to the reduction of
docked vesicles observed at theC. elegans neuromuscular junc-
tion and account for the unusually severe defect in evoked
release. In this model, complexin stabilizes the SNARE complex
and hence increases the number of primed vesicles. Again, the
elegance of this model is its simplicity: complexin stabilizes the
docked state. However, we cannot exclude the possibility that
complexinplaysamoredirect role inevoked release, for example
via regulatory interactions with synaptotagmin.Species Diversity
How can we reconcile contradictory data for complexin
mutants in different experimental systems? In themouse, com-
plexin primarily stimulates evoked release, whereas in flies it
primarily blocks spontaneous release. In the worm, complexin
plays a prominent role in both functions: complexin is essential
for evoked release, and it blocks spontaneous fusion.
However, these differences among species are ones of degree:
inhibitory and stimulatory functions for complexin are found in
each organism. Given the strong sequence conservation, it is
likely that complexin is playing similar roles at all synapses,
its character shaped by the other players at the synapse. It
seems that complexin encompasses schizophrenic roles in
exocytosis: it both blocks and stimulates fusion.Experimental Procedures
Constructs and Strains
All constructs were made using standard molecular biology techniques and
Gateway technology (Invitrogen). For a full description of how all constructs
were made, see the Supplemental Experimental Procedures. Either
rescuing or reporter constructs were microinjected into the worm gonads
to produce progeny carrying extrachromosomal arrays or single copy inser-
tions of rescuing or mutant complexins were produced using MosSCI, as
previously described [25]. For a full description of the methodologies
used to create transgenic C. elegans, see the Supplemental Experimental
Procedures.Behavioral Assays
Thrashing assays were performed as previously
described [28] and are fully described in the Supple-
mental Experimental Procedures. For the aldicarb
assays, 20–25 worms were added to the center of
room-temperature aldicarb plates and scored for paral-
ysis after 4 hr. The assays are fully described in the
Supplemental Experimental Procedures. For heat-shock
experiments, strains were heat shocked for 1 hr at 34C
and then allowed to recover at room temperature for 6 hr prior to assay.
For heat-shock aldicarb assays, 20–25 worms were added to a plate con-
taining 1 mM aldicarb and scored for paralysis every 15 min.
Confocal Microscopy
Worms were immobilized in 2% phenoxypropanol in M9 solution on freshly
made 2% agarose pads. Images were acquired on a Pascal LSM5 confocal
microscope (Zeiss) with a 633 1.4NA oil objective. For imaging of the dorsal
nerve cord, worms were imaged with the dorsal surface facing toward the
objective. For each of the synaptic markers, a Z stack was taken of
a 70 mm section of nerve cord, and the total number of GFP-positive puncta
was counted.
Electrophysiology
Young adult hermaphrodite animals were used for electrophysiological
analysis. Miniature and evoked postsynaptic currents (mPSCs and ePSCs)
at the neuromuscular junction were recorded as previously described [21,
29]. For a full description of electrophysiological methods and analysis,
see the Supplemental Experimental Procedures. Data were imported into
Origin, version 7.5 (OriginLab) for graphing and statistical analysis. Unpaired
t test was used for statistical comparisons. p < 0.05 is considered statisti-
cally significant.
Electron Microscopy
N2 and cpx-1(ok1552) worms were fixed in parallel for electron microscopy
using high-pressure freezing followed by substitution of solvent-based fixa-
tives, as previously described [30–32]. For a full description of the electron
microscopy methods, see the Supplemental Experimental Procedures.
Allmorphometrywas conductedblind togenotype and included amatched
wild-type worm that was fixed in parallel. The number of synaptic vesicles
(w30 nm in diameter) in each synaptic profile was counted, and their
distances from the dense projection and plasmamembrane were measured.
Docked vesicles were defined as touching the plasma membrane. Analysis
included the acetylcholine neurons VA and VB and the GABA neuron VD.
Reagents
All chemicals were purchased from Sigma-Aldrich and all molecular
reagents from Invitrogen and New England Biolabs, unless otherwise
stated. Worm strains not generated in the lab were ordered from the Caeno-
rhabditis Genetics Center (http://www.cbs.umn.edu/CGC/).Supplemental Information
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and one table and can be foundwith this article online at doi:10.
1016/j.cub.2010.12.015.
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